window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : November 16, 2025

  • News
  • About Us
Contact Us

clinical trial supply

  • Biomanufacturing,Clinical Trials,European biotech,Pharmaceuticals and therapeutics,Regulatory Affairs,Supply Chain & Logistics

    Klifo receives regulatory approval for new clinical trial supply facility in Copenhagen

    KLIFO, Europe’s largest independent provider of clinical trial supply (CTS) [...]

    October 9, 2025
  • CDMOs & Manufacturing,Supply Chain & Logistics,Technology and platforms

    Sharp’s climate targets validated by SBTi as company commits to 90% emissions reduction by 2050

    Packaging and clinical trial services provider Sharp strengthens its climate [...]

    July 16, 2025
  • Clinical Trials,Partnerships & Funding,Patient Centricity

    New partnership aims to tackle European shortages of key oncology drugs

    Bionical Emas has signed an exclusive global clinical trial supply [...]

    May 29, 2025
  • Partnerships & Funding

    RoosterBio and Thermo Fisher team up to accelerate cell and exosome therapy manufacturing

    April 29, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Clairity raises $43 million to launch FDA-authorized AI platform for breast cancer risk prediction
    Categories: Artificial Intelligence, Biotech, Clinical Development, Diagnostics, Digital Health, Drug Development, Global health, Healthcare leadership, Precision medicine, Women's Health
  • FDA approves Kura and Kyowa Kirin’s ziftomenib for relapsed or refractory AML
    Categories: Drug approval, Oncology, Pharmaceuticals and therapeutics
  • Successful treatment for ALS could deliver billions in global value
    Categories: Neurosciences, Rare Diseases, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top